Brainstorm Cell Therapeutics Inc.

Go to Brainstorm Cell Therapeutics Inc. Website

$0.67

-0.02 (-3.62%)
Live
Previous Close

$0.69

Day Range

$0.64 - $0.69

Previous Day Range

$0.67 - $0.69

Market Cap

$ USD

Day Vol.

13106

Previous Day Vol.

25459

Currency

USD

Primary Exchange

Nasdaq

BRAINSTORM CELL THERAPUTC...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Brainstorm Cell Therapeutics voluntarily delisted from Nasdaq due to non-compliance with shareholder equity requirements, with stock price dropping 42.74%. The company will continue trading on OTCQB Venture Market and remains committed to developing NurOwn therapy for ALS.

Related tickers: BCLI.

Read Full Article

BrainStorm Cell Therapeutics will present new insights into cerebrospinal fluid biomarkers associated with its investigational cell therapy NurOwn, which is being evaluated in an upcoming Phase 3b trial for amyotrophic lateral sclerosis (ALS).

Related tickers: BCLI.

Read Full Article
Trending Tickers

Please sign in to view